Information:
Notice: Website under construction,
 

"Test The Rest" Campaign
Vietnam Era Veterans Hepatitis C Testing Enhancement Act
Action Needed!!
 
Jetguns- Bringing down hep-c
American Legion Post 1619 is urging all Vietnam vets to get tested

 
Jet guns should be a recognized risk factor for hepatitis C
By PAUL HARASIM / RJ
A number of veterans as well as doctors now believe that Vietnam veterans...could have contracted hepatitis C through unsafe jet gun vaccinations.


 
Forget stigma, boomers: Get tested for hepatis C
By PAUL HARASIM / RJ
While it’s possible the government’s position on transmission of hepatitis C among boomers may have resulted in less testing, it’s critical today boomers forget any fears of stigma and get the easy blood test.
 
Newsweek-
VA's Hepatitis C Problem    
By Gerard Flynn

 
Orange Count Registry
Vietnam vets blame 'jet guns' for their hepatitis C
By Lily Leung Feb. 14, 2016 
 

By Judith Graham
VA Extends New Hepatitis C Drugs to All Veterans in Its Health System

 

 
Denied Hep C VA dental care?
Please click here

 
Dried Hepatitis C Blood Exposure 11/23/2013 Weeks later inconspicuous blood transmits virus and more likely to cause accidental exposures to Hep C
 

Lack of Standards
Mass Vaccinations
1970 Jetgun Nursing Instructions
 

2014 AASLD Study Hepatitis C not an STD

Home
Documentation & Surveillance Alerts
Military Hepatitis History  
Understanding The Liver 
VA Flow Sheet for Cirrhosis
VA Defines Risk Factors
 
Hep C & Pro-Prebiotic
Need to know-Grassroots Research
 
Blog Another12Weeks
One Vets' Journey Though Treatment
 

 Ask NOD
 What Would Veterans Do?
Blog for VA Claims
 

HadIt.com Members Forum
Help with VA Claims
 


 
Info: Plan Backfires-
VBA Fast Letter Boost Claims
 
Disability Ratings
Does Your Medical Record Show Hep C Related Diseases?
The Liver and Hepatitis C

 
Legal- Fed Regs state:
Judge decision may be relied upon
Cotant v. Principi, 17 Vet.App. 116, 134 (2003),
 
Service Connected Claims
# 1 Conclusion of Law 
# 2 Conclusion of Law 
 
More Claims
Jetgun Decisions
Hep C Decisions
 
Search Board of Appeals Website
BVA Jetgun Decisions
BVA Hepatitis C Decisions

Great Advice!  
After the jetgun win
What to do next


Follow HCVets.com
@HCVeterans


 

 

HCV RNA genome were carried out on bone marrow (BM) and peripheral blood (PB) mononuclear cells (MC) of 11 chronically HCV-infected patients. In four patients (36·4%) HCV antigens were detected in monocytes/macrophages as well as in B lymphocytes in both BMMC and PBMC.

These results demonstrate that HCV can infect BMMC and PBMC that represent important extrahepatic sites of virus replication, and may help to explain the immunological abnormalities observed in chronic HCV carriers.

Journal List > Clin Exp Immunol > v.103(3); Mar 1996

Formats:

  • Summary|
  • PDF (4.0M)
 
   
Clin Exp Immunol. 1996 March; 103(3): 414–421.
doi: 10.1111/j.1365-2249.1996.tb08296.x.
PMCID: PMC2200370
Copyright © 1996 Blackwell Science
Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients

D. SANSONNO, A. R. IACOBELLI, V. CORNACCHIULO, G. IODICE, and F. DAMMACCO

Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy

 

Correspondence: Franco Dammacco MD, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Policlinico, Piazza G. Cesare, 11-70124 Bari, Italy.

 

Accepted October 31, 1995.
Small right arrow pointing to: This article has been cited by other articles in PMC.

 

Abstract
Immunofluorescence (IF) to detect HCV antigens and non-isotopic in situ hybridization (NISH) to detect HCV RNA genome were carried out on bone marrow (BM) and peripheral blood (PB) mononuclear cells (MC) of 11 chronically HCV-infected patients. In four patients (36·4%) HCV antigens were detected in monocytes/macrophages as well as in B lymphocytes in both BMMC and PBMC. Positive T lymphocytes in BMMC were found in three of them, but only one patient showed positive T cells in PBMC. NISH invariably demonstrated minus and plus HCV RNA genomic strands either in monocytes/macrophages or B and T lymphocytes in BMMC and PBMC in the four HCV antigen-positive patients and in two further patients not expressing viral proteins in blood MC. IF signals appeared diffusely distributed within the cytoplasm, or as brilliant granules in distinct submembrane areas or else in cytoplasm membrane. Nuclei never stained. Similarly, NISH displayed HCV RNA accumulation restricted to MC cytoplasm only, nuclei being persistently negative. NISH, however, was unable to detect cell membrane signal. Infection of blood MC is a common event in naturally acquired HCV infection, since none of these patients was conditioned by immunomodulating or immunosuppressive therapies. No difference was found in terms of mean age, length of disease, anti-HCV immune response, type and severity of chronic liver damage between patients with HCV-infected MC and patients without cell infection. These results demonstrate that HCV can infect BMMC and PBMC that represent important extrahepatic sites of virus replication, and may help to explain the immunological abnormalities observed in chronic HCV carriers.

 

Full Text
The Full Text of this article is available as a PDF (4.0M).

 

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
1. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull. 1990;46:423–41. [PubMed]
2. Colombo M, Choo QL, Del Ninno E, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989;2:1006–8. [PubMed]
3. Gerber MA, Shieh YSC, Shim K-S, et al. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol. 1992;141:1271–7. [PMC free article] [PubMed]
4. Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Brechot C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of low-endemic area. Hepatology. 1993;17:20–29. [PubMed]
5. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991;14:381–8. [PubMed]
6. Choo QL, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 1991;88:2451–5. [PMC free article] [PubMed]
7. Dienstag JL. Hepatitis non-A, non-B: C at last. Gastroenterology. 1990;99:1177–80. [PubMed]
8. Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, Walker CM. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol. 1993;151:4189–99. [PubMed]
9. Minutello AM, Pileri P, Unutmatz D, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells, specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med. 1993;178:17–25. [PMC free article] [PubMed]
10. Ferrari C, Valli A, Galati L, et al. T-cell response to structural and nonstructural hepatitis C virus infections. Hepatology. 1994;19:286–95. [PubMed]
11. Alter HJ. To C or not to C: these are the questions. Blood. 1995;85:1681–95. [PubMed]
12. Krawczynski K, Beach MJ, Bradley DW, et al. Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. Gastroenterology. 1992;103:622–9. [PubMed]
13. Hiramatsu N, Hayashi N, Haruna Y, et al. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology. 1992;16:306–11. [PubMed]
14. Sansonno D, Dammacco F. Hepatitis C virus c100 antigen in liver tissue from patients with acute and chronic infection. Hepatology. 1993;18:240–5. [PubMed]
15. Blight K, Lesniewski RR, Labrooy JT, Gowans EJ. Detection and distribution of hepatitis C-specific antigens in naturally infected liver. Hepatology. 1994;20:553–7. [PubMed]
16. Negro F, Pacchioni D, Shimizu Y, Miller RH, Bussolati G, Purcell RH, Bonino F. Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci USA. 1992;89:2247–51. [PMC free article] [PubMed]
17. Yamada S, Kojl T, Nozawa M, Kiyosama K, Nakane PK. Detection of hepatitis C virus (HCV) RNA in paraffin embedded tissue sections of human liver of non-A, non-B hepatitis patients by in situ hybridization. J Clin Lab Anal. 1992;6:40–46. [PubMed]
18. Tigges MA, Koelle D, Hartog K, Sekulovich RE, Corey L, Burke RL. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. J Virol. 1992;66:1622–34. [PMC free article] [PubMed]
19. Oldstone MBA. Viral persistence. Cell. 1989;56:517–20. [PubMed]
20. Lamelin JP, Zoulim F, Trepo C. Lymphotropism of hepatitis B and C virus: an update and a newcomer. Int J Clin Lab Res. 1995;25:1–6. [PubMed]
21. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis. 1992;166:1276–80. [PubMed]
22. Zignego AL, Macchia D, Monti M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol. 1992;15:382–6. [PubMed]
23. Bartolomθ J, Castillo I, Quiroga JA, Navas S, Carreno V. Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells. J Hepatol. 1993;17:s90–s93. [PubMed]
24. Ferri C, Monti M, La Civita L, et al. Infection of peripheral blood-mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood. 1993;82:3701–4. [PubMed]
25. Gabrielli A, Manzin A, Candela M, Caniglia ML, Paolucci S, Danieli MG, Clementi M. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinemia. Clin Exp Immunol. 1994;97:87–93. [PMC free article] [PubMed]
26. Moldvay J, Deny P, Pol S, Brechot C, Lamas E. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization. Blood. 1994;83:269–73. [PubMed]
27. Gutierrez C, Bernabe RR, Vega J, Kreisler M. Purification of human T and B cells by a discontinuous density gradient of Percoll. J Immunol Methods. 1979;29:57–63. [PubMed]
28. Houghton M, Choo QL, Kuo G. European Patent Application. Publication no. 0318216 and no. 0388232.
29. Yamada G, Nishimoto H, Endou H, et al. Localization of hepatitis C viral RNA and capsid protein in human liver. Dig Dis Sci. 1993;38:882–7. [PubMed]
30. Schmitz GG, Walter T, Seibl R, Kessler C. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem. 1991;192:222–31. [PubMed]
31. Eggerding FA, Peters J, Lee RK, Inderlied CB. Detection of rubella virus gene sequences by enzymatic amplification and direct sequencing of amplified DNA. J Clin Microbiol. 1991;29:945–52. [PMC free article] [PubMed]
32. Dammacco F, Sansonno D, Beardsley A, Gowans EJ. Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti-HCV-positive intravenous immunoglobulins. Clin Exp Immunol. 1993;92:205–10. [PMC free article] [PubMed]
33. Gudat F, Bianchi L. Evidence for phasic sequences in nuclear HBcAg formation and cell membrane-directed flow of core particles in chronic hepatitis B. Gastroenterology. 1977;73:1194–7. [PubMed]
34. Cleaves GR, Ryan TE, Schlesinger RW. Identification and characterization of type 2 Dengue virus replicative form RNAs. Virology. 1981;111:73–83. [PubMed]
35. Halstead SB, O'Rourke EJ. Antibody-enhanced Dengue virus infection in primate leukocytes. Nature. 1977;265:739–74. [PubMed]
36. Peiris JSM, Porterfield JS. Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature. 1979;282:509–11. [PubMed]
37. Porterfield JS. Antibody-dependent enhancement of viral infectivity. In: Maramorosch K, Murphy FA, Shatkin AJ, editors. Advances in virus research. Vol. 31. London: Academic Press Inc; 1986. pp. 335–55.
38. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244:362–4. [PubMed]
39. Sansonno D, Dammacco F. Antibodies to hepatitis C virus in non-A, non-B post transfusion and cryptogenetic chronic liver disease. Lancet. 1989;ii:798–9. [PubMed]
40. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490–5. [PubMed]
41. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA. 1993;90:8234–8. [PMC free article] [PubMed]
42. Sansonno D, Procaccio P, Dammacco F. Kinetics of anti-hepatitis C virus response during acute hepatitis in an immunosuppressed HCV-chronically infected patient. Digestion. 1991;50:52–60. [PubMed]
43. Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM. Withdrawal of immunosuppressive therapy in allogenic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant. 1991;8:417–20. [PubMed]
44. Dammacco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia. Clin Exp Immunol. 1992;87:352–6. [PMC free article] [PubMed]
45. Lunel F, Musset L, Franjeul L, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 1994;106:1291–300. [PubMed]
46. Lunel F. Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology. 1994;107:1550–5. [PubMed]
47. Sansonno D, Cornacchiulo V, Iacobelli AR, Di Stefano R, Lospalluti M, Dammacco F. Localization of hepatitis C virus (HCV) antigens in liver and skin tissues of chronically HCV-infected patients with mixed cryoglobulinemia. Hepatology. 1995;21:305–12. [PubMed]

 

Site Map

Medical Risks Blood Products & Vaccines Red Cross Legal Actions
Provider Risks Jet/Air Gun Vaccinations Federal Agencies Military Files
Dental Risk Injection Equipment Scientific Journals Tattoos & Piercing
  Immune Serum Globulin Media Articles Shared Items

For problems or questions regarding this Web site contact
Contact
 HCVets.com
Revised: June 02, 2016

FAIR USE NOTICE